Israel
# |
Name |
Revenue Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 22.91
|
Dec. 31, 2023 | USD 20.06 | -0.66% |
|
Israel |
|
2 |
USD 17.24
|
Dec. 31, 2023 | USD 2.26 | -2.59% |
|
Israel |
|
3 |
USD 14.17
|
Dec. 31, 2023 | USD 20.86 | -2.64% |
|
Israel |
|
4 |
USD 7.82
|
Dec. 31, 2023 | USD 3.80 | 0.26% |
|
Israel |
|
5 |
USD 4.40
|
Dec. 31, 2023 | USD 2.73 | -8.00% |
|
Israel |
|
6 |
USD 2.85
|
Dec. 31, 2023 | USD 1.20 | 0.92% |
|
Israel |
|
7 |
USD 2.58
|
Dec. 31, 2023 | USD 7.30 | -3.84% |
|
Israel |
|
8 |
USD 2.15
|
Dec. 31, 2023 | USD 1.65 | -1.71% |
|
Israel |
|
9 |
USD 2.07
|
Dec. 31, 2023 | USD 19.02 | 3.99% |
|
Israel |
|
10 |
USD 1.47
|
Dec. 31, 2023 | USD 4.46 | 11.46% |
|
Israel |
|
11 |
USD 1.22
|
Dec. 31, 2023 | USD 0.84 | 0.91% |
|
Israel |
|
12 |
USD 1.08
|
Dec. 31, 2023 | USD 6.13 | 0.95% |
|
Israel |
|
13 |
USD 1.07
|
Dec. 31, 2023 | USD 2.04 | NA |
|
Israel |
|
14 |
USD 1.01
|
Dec. 31, 2023 | USD 5.51 | -1.08% |
|
Israel |
|
15 |
USD 0.96
|
Dec. 31, 2023 | USD 3.84 | -2.29% |
|
Israel |
|
16 |
USD 0.96
|
Dec. 31, 2023 | USD 4.83 | -0.52% |
|
Israel |
|
17 |
USD 0.89
|
Dec. 31, 2023 | USD 0.52 | -0.27% |
|
Israel |
|
18 |
USD 0.40
|
Dec. 31, 2023 | USD 0.73 | -4.24% |
|
Israel |
|
19 |
USD 0.38
|
Dec. 31, 2023 | USD 1.85 | 10.75% |
|
Israel |
|
20 |
USD 0.26
|
Dec. 31, 2023 | USD 2.67 | 0.76% |
|
Israel |
|
21 |
USD 0.22
|
Dec. 31, 2023 | USD 1.21 | 0.04% |
|
Israel |
|
22 |
USD 0.19
|
Dec. 31, 2023 | USD 0.11 | 0.81% |
|
Israel |
|
23 |
USD 0.18
|
Dec. 31, 2023 | USD 7.48 | 1.22% |
|
Israel |
|
24 |
USD 0.16
|
Dec. 31, 2023 | USD 0.87 | 0.07% |
|
Israel |
|
25 |
USD 0.12
|
Dec. 31, 2023 | USD 1.59 | 0.10% |
|
Israel |
|
26 |
USD 0.09
|
Dec. 31, 2023 | USD 2.58 | -3.90% |
|
Israel |
|
27 |
USD 0.08
|
Dec. 31, 2023 | USD 0.07 | 0.45% |
|
Israel |
|
28 |
USD 0.07
|
Dec. 31, 2023 | USD 1.24 | 5.08% |
|
Israel |
|
29 |
USD 0.07
|
Dec. 31, 2023 | USD 0.08 | 0.04% |
|
Israel |
|
30 |
USD 0.06
|
June 30, 2024 | USD 4.33 | -2.68% |
|
Israel |
|
31 |
USD 0.05
|
Dec. 31, 2023 | USD 0.09 | -0.28% |
|
Israel |
|
32 |
USD 0.03
|
Dec. 31, 2023 | USD 0.19 | 1.64% |
|
Israel |
|
33 |
USD 0.01
|
Dec. 31, 2023 | USD 0.20 | -2.14% |
|
Israel |
|
34 |
USD 0.00
|
Dec. 31, 2023 | USD 0.01 | -11.50% |
|
Israel |
|
35 |
USD 0.00
|
Dec. 31, 2023 | USD 0.51 | 17.58% |
|
Israel |
|
36 |
USD 0.00
|
Dec. 31, 2023 | USD 0.02 | -1.36% |
|
Israel |
|
37 |
USD 0.00
|
Dec. 31, 2023 | USD 0.01 | 0.04% |
|
Israel |
|
38 |
USD 0.00
|
Dec. 31, 2023 | USD 0.20 | 2.02% |
|
Israel |
|
39 |
USD 0.00
|
Dec. 31, 2023 | USD 0.19 | -0.67% |
|
Israel |
|
40 |
USD 0.00
|
Dec. 31, 2023 | USD 0.02 | 1.63% |
|
Israel |
|
41 |
USD 0.00
|
Dec. 31, 2023 | USD 0.51 | -4.99% |
|
Israel |
|
42 |
USD 0.00
|
Dec. 31, 2023 | USD 2.74 | -3.52% |
|
Israel |
|
43 |
USD 0.00
|
Dec. 31, 2023 | USD 4.00 | 8.11% |
|
Israel |
|
44 |
USD 0.00
|
Dec. 31, 2023 | USD 2.82 | -2.08% |
|
Israel |
|
45 |
USD 0.00
|
Dec. 31, 2023 | USD 1.03 | -0.96% |
|
Israel |
|
46 |
USD 0.00
|
Dec. 31, 2023 | USD 0.09 | -4.99% |
|
Israel |
|
47 |
USD 0.00
|
Dec. 31, 2023 | USD 0.19 | 2.52% |
|
Israel |
|
48 |
USD 0.00
|
Dec. 31, 2023 | USD 2.36 | -1.67% |
|
Israel |
|
49 |
USD 0.00
|
Dec. 31, 2023 | USD 3.09 | 5.46% |
|
Israel |
|
50 |
USD 0.00
|
Dec. 31, 2023 | USD 1.16 | -2.88% |
|
Israel |
The Health Care company in Israel with the highest Revenue Per Share is Ilex Medical Ltd (Tel Aviv Stock Exchange: ILX.TA) at USD 22.91.
The Health Care company in Israel with the lowest Revenue Per Share is Bonus BioGroup Ltd. (Tel Aviv Stock Exchange: BONS.TA) at USD 0.00.
The top 10 Health Care companies in Israel by Revenue Per Share are Ilex Medical Ltd, IM Cannabis Corp., Teva Pharmaceutical Industries Limited, Rekah Pharmaceutical Industry Ltd., SHL Telemedicine Ltd., Together Pharma Ltd, Kamada Ltd., InterCure Ltd., MediWound Ltd. and SofWave Medical Ltd..
The bottom 10 Health Care companies in Israel by Revenue Per Share are Bonus BioGroup Ltd., Steakholder Foods Ltd., Sonovia Ltd., Chemomab Therapeutics Ltd., Scinai Immunotherapeutics Ltd., Kadimastem Ltd, Enlivex Therapeutics Ltd., PolyPid Ltd., Entera Bio Ltd. and Nextgen Biomed Ltd.